- Home
- CLDX vs CMRE Comparison
CLDX vs CMRE Comparison
Compare CLDX & CMRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- CMRE
- Stock Information
- Founded
- CLDX N/A
- CMRE 1974
- Country
- CLDX United States
- CMRE Monaco
- Employees
- CLDX N/A
- CMRE N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CMRE Marine Transportation
- Sector
- CLDX Health Care
- CMRE Consumer Discretionary
- Exchange
- CLDX Nasdaq
- CMRE Nasdaq
- Market Cap
- CLDX 1.3B
- CMRE 1.0B
- IPO Year
- CLDX 2008
- CMRE 2010
- Fundamental
- Price
- CLDX $21.35
- CMRE $9.17
- Analyst Decision
- CLDX Buy
- CMRE Hold
- Analyst Count
- CLDX 9
- CMRE 2
- Target Price
- CLDX $50.00
- CMRE $13.50
- AVG Volume (30 Days)
- CLDX 1.0M
- CMRE 511.5K
- Earning Date
- CLDX 08-07-2025
- CMRE 07-30-2025
- Dividend Yield
- CLDX N/A
- CMRE 5.02%
- EPS Growth
- CLDX N/A
- CMRE N/A
- EPS
- CLDX N/A
- CMRE 2.44
- Revenue
- CLDX $7,559,000.00
- CMRE $2,054,690,000.00
- Revenue This Year
- CLDX N/A
- CMRE N/A
- Revenue Next Year
- CLDX N/A
- CMRE N/A
- P/E Ratio
- CLDX N/A
- CMRE $3.76
- Revenue Growth
- CLDX 24.49
- CMRE 18.22
- 52 Week Low
- CLDX $14.40
- CMRE $6.63
- 52 Week High
- CLDX $47.00
- CMRE $17.58
- Technical
- Relative Strength Index (RSI)
- CLDX 59.74
- CMRE 59.44
- Support Level
- CLDX $19.25
- CMRE $8.41
- Resistance Level
- CLDX $20.56
- CMRE $8.65
- Average True Range (ATR)
- CLDX 1.13
- CMRE 0.21
- MACD
- CLDX 0.04
- CMRE 0.10
- Stochastic Oscillator
- CLDX 97.22
- CMRE 99.49
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About CMRE Costamare Inc. $0.0001 par value
Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and among others. Costamare provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.